메뉴 건너뛰기




Volumn 155, Issue 10, 2014, Pages 3817-3828

GLP-1 analog liraglutide enhances proinsulin processing in pancreatic β-cells via a PKA-dependent pathway

Author keywords

[No Author keywords available]

Indexed keywords

9 (TETRAHYDRO 2 FURYL)ADENINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXENDIN 9 39; FORSKOLIN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUCOSE; HORMONE RECEPTOR BLOCKING AGENT; INSULIN; LIRAGLUTIDE; MESSENGER RNA; PROINSULIN; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; PROPROTEIN CONVERTASE 3; UNCLASSIFIED DRUG; GLUCAGON LIKE PEPTIDE 1;

EID: 84907191530     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1218     Document Type: Article
Times cited : (18)

References (57)
  • 1
    • 67649126340 scopus 로고    scopus 로고
    • Impact of sitagliptin on markers of-cell function: A meta-analysis
    • Riche DM, East HE, Riche KD. Impact of sitagliptin on markers of-cell function: a meta-analysis. Am J Med Sci. 2009;337:321-328.
    • (2009) Am J Med Sci , vol.337 , pp. 321-328
    • Riche, D.M.1    East, H.E.2    Riche, K.D.3
  • 2
    • 60549111796 scopus 로고    scopus 로고
    • A biomarker concept for assessment of insulin resistance,-cell function and chronic systemic inflammation in type 2 diabetes mellitus
    • Pfutzner A, Weber MM, Forst T. A biomarker concept for assessment of insulin resistance,-cell function and chronic systemic inflammation in type 2 diabetes mellitus. Clin Lab. 2008;54:485-490.
    • (2008) Clin Lab , vol.54 , pp. 485-490
    • Pfutzner, A.1    Weber, M.M.2    Forst, T.3
  • 3
    • 0034500397 scopus 로고    scopus 로고
    • Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic-cell
    • Goodge KA, Hutton JC. Translational regulation of proinsulin biosynthesis and proinsulin conversion in the pancreatic-cell. Semin Cell Dev Biol. 2000;11:235-242.
    • (2000) Semin Cell Dev Biol , vol.11 , pp. 235-242
    • Goodge, K.A.1    Hutton, J.C.2
  • 4
    • 0026726773 scopus 로고
    • Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3
    • Smeekens SP, Montag AG, Thomas G, et al. Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3. Proc Natl Acad Sci USA. 1992;89:8822-8826.
    • (1992) Proc Natl Acad Sci USA , vol.89 , pp. 8822-8826
    • Smeekens, S.P.1    Montag, A.G.2    Thomas, G.3
  • 5
    • 0036679173 scopus 로고    scopus 로고
    • Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects
    • Zhu X, Zhou A, Dey A, et al. Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA. 2002;99:10293-10298.
    • (2002) Proc Natl Acad Sci USA , vol.99 , pp. 10293-10298
    • Zhu, X.1    Zhou, A.2    Dey, A.3
  • 6
    • 0346096721 scopus 로고    scopus 로고
    • Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency
    • Jackson RS, Creemers JW, Farooqi IS, et al. Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency. J Clin Invest. 2003;112:1550-1560.
    • (2003) J Clin Invest , vol.112 , pp. 1550-1560
    • Jackson, R.S.1    Creemers, J.W.2    Farooqi, I.S.3
  • 7
    • 12644253798 scopus 로고    scopus 로고
    • Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2
    • Furuta M, Yano H, Zhou A, et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA. 1997;94:6646-6651.
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 6646-6651
    • Furuta, M.1    Yano, H.2    Zhou, A.3
  • 8
    • 77953199189 scopus 로고    scopus 로고
    • Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion
    • Heni M, Haupt A, Schafer SA, et al. Association of obesity risk SNPs in PCSK1 with insulin sensitivity and proinsulin conversion. BMC Med Genet. 2010;11:86.
    • (2010) BMC Med Genet , vol.11 , pp. 86
    • Heni, M.1    Haupt, A.2    Schafer, S.A.3
  • 9
    • 84855186825 scopus 로고    scopus 로고
    • Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population
    • Zheng X, Ren W, Zhang S, et al. Association of type 2 diabetes susceptibility genes (TCF7L2, SLC30A8, PCSK1 and PCSK2) and proinsulin conversion in a Chinese population. Mol Biol Rep. 2012; 39:17-23.
    • (2012) Mol Biol Rep , vol.39 , pp. 17-23
    • Zheng, X.1    Ren, W.2    Zhang, S.3
  • 10
    • 80051937658 scopus 로고    scopus 로고
    • Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin
    • Wagner R, Dudziak K, Herzberg-Schafer SA, et al. Glucose-raising genetic variants in MADD and ADCY5 impair conversion of proinsulin to insulin. PLoS One. 2011;6:e23639.
    • (2011) PLoS One , vol.6 , pp. e23639
    • Wagner, R.1    Dudziak, K.2    Herzberg-Schafer, S.A.3
  • 11
    • 77954145177 scopus 로고    scopus 로고
    • CommonPCSK1 haplotypes are associated with obesity in the Chinese population
    • Chang YC, Chiu YF, Shih KC, et al.CommonPCSK1 haplotypes are associated with obesity in the Chinese population. Obesity (Silver Spring). 2010;18:1404-1409.
    • (2010) Obesity (Silver Spring) , vol.18 , pp. 1404-1409
    • Chang, Y.C.1    Chiu, Y.F.2    Shih, K.C.3
  • 12
    • 59449100327 scopus 로고    scopus 로고
    • Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3)
    • Wen JH, Chen YY, Song SJ, et al. Paired box 6 (PAX6) regulates glucose metabolism via proinsulin processing mediated by prohormone convertase 1/3 (PC1/3). Diabetologia. 2009;52:504-513.
    • (2009) Diabetologia , vol.52 , pp. 504-513
    • Wen, J.H.1    Chen, Y.Y.2    Song, S.J.3
  • 13
    • 33847617011 scopus 로고    scopus 로고
    • Mechanisms of action of glucagon-like peptide 1 in the pancreas
    • Doyle ME, Egan JM. Mechanisms of action of glucagon-like peptide 1 in the pancreas. Pharmacol Ther. 2007;113:546-593.
    • (2007) Pharmacol Ther , vol.113 , pp. 546-593
    • Doyle, M.E.1    Egan, J.M.2
  • 15
    • 59449101432 scopus 로고    scopus 로고
    • Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): A randomised, 52-week, phase III, double-blind, parallel-treatment trial
    • Garber A, Henry R, Ratner R, et al. Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial. Lancet. 2009;373:473-481.
    • (2009) Lancet , vol.373 , pp. 473-481
    • Garber, A.1    Henry, R.2    Ratner, R.3
  • 16
    • 39749143348 scopus 로고    scopus 로고
    • Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic-cell function and argininestimulated insulin secretion during hyperglycaemia in patients with type 2 diabetes mellitus
    • Vilsboll T, Brock B, Perrild H, et al. Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic-cell function and argininestimulated insulin secretion during hyperglycaemia in patients with type 2 diabetes mellitus. Diabet Med. 2008;25:152-156.
    • (2008) Diabet Med , vol.25 , pp. 152-156
    • Vilsboll, T.1    Brock, B.2    Perrild, H.3
  • 17
    • 2542451393 scopus 로고    scopus 로고
    • Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): A 12-week, double-blind, randomized, controlled trial
    • Madsbad S, Schmitz O, Ranstam J, Jakobsen G, Matthews DR. Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial. Diabetes Care. 2004;27: 1335-1342.
    • (2004) Diabetes Care , vol.27 , pp. 1335-1342
    • Madsbad, S.1    Schmitz, O.2    Ranstam, J.3    Jakobsen, G.4    Matthews, D.R.5
  • 18
    • 7444228521 scopus 로고    scopus 로고
    • Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
    • Buse JB, Henry RR, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Diabetes Care. 2004;27:2628-2635.
    • (2004) Diabetes Care , vol.27 , pp. 2628-2635
    • Buse, J.B.1    Henry, R.R.2    Han, J.3    Kim, D.D.4    Fineman, M.S.5    Baron, A.D.6
  • 19
    • 33845489598 scopus 로고    scopus 로고
    • Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus
    • Raz I, Hanefeld M,XuL, Caria C, Williams-Herman D, Khatami H. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia. 2006;49:2564-2571.
    • (2006) Diabetologia , vol.49 , pp. 2564-2571
    • Raz, I.1    Hanefeld, M.2    Xu, L.3    Caria, C.4    Williams-Herman, D.5    Khatami, H.6
  • 20
    • 33845472504 scopus 로고    scopus 로고
    • Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes
    • Aschner P, Kipnes MS, Lunceford JK, Sanchez M, Mickel C, Williams-Herman DE. Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes. Diabetes Care. 2006;29:2632-2637.
    • (2006) Diabetes Care , vol.29 , pp. 2632-2637
    • Aschner, P.1    Kipnes, M.S.2    Lunceford, J.K.3    Sanchez, M.4    Mickel, C.5    Williams-Herman, D.E.6
  • 21
    • 84862611349 scopus 로고    scopus 로고
    • Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival
    • Nakashima K, Shimoda M, Hamamoto S, et al. Self-inducible secretion of glucagon-like peptide-1 (GLP-1) that allows MIN6 cells to maintain insulin secretion and insure cell survival. Mol Cell Endocrinol. 2012;349:281-288.
    • (2012) Mol Cell Endocrinol , vol.349 , pp. 281-288
    • Nakashima, K.1    Shimoda, M.2    Hamamoto, S.3
  • 22
    • 0035046251 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism
    • Wang X, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic-cells by a cyclic adenosine monophosphate/protein kinase A-dependent mechanism. Endocrinology. 2001;142:1820-1827.
    • (2001) Endocrinology , vol.142 , pp. 1820-1827
    • Wang, X.1    Zhou, J.2    Doyle, M.E.3    Egan, J.M.4
  • 23
    • 0033769693 scopus 로고    scopus 로고
    • CAMP-GEFII is a direct target of cAMP in regulated exocytosis
    • Ozaki N, Shibasaki T, Kashima Y, et al. cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol. 2000;2:805-811.
    • (2000) Nat Cell Biol , vol.2 , pp. 805-811
    • Ozaki, N.1    Shibasaki, T.2    Kashima, Y.3
  • 24
    • 84857796399 scopus 로고    scopus 로고
    • Elevated intact proinsulin levels are indicative of-cell dysfunction, insulin resistance, and cardiovascular risk: Impact of the antidiabetic agent pioglitazone
    • Pfutzner A, Forst T. Elevated intact proinsulin levels are indicative of-cell dysfunction, insulin resistance, and cardiovascular risk: impact of the antidiabetic agent pioglitazone. J Diabetes Sci Technol. 2011;5:784-793.
    • (2011) J Diabetes Sci Technol , vol.5 , pp. 784-793
    • Pfutzner, A.1    Forst, T.2
  • 25
    • 0031791047 scopus 로고    scopus 로고
    • Disproportionately elevated proinsulin levels reflect the degree of impaired cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
    • Roder ME, Porte DJ, Schwartz RS, Kahn SE. Disproportionately elevated proinsulin levels reflect the degree of impaired cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1998;83:604-608.
    • (1998) J Clin Endocrinol Metab , vol.83 , pp. 604-608
    • Roder, M.E.1    Porte, D.J.2    Schwartz, R.S.3    Kahn, S.E.4
  • 26
    • 0025268864 scopus 로고
    • Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus
    • Saad MF, Kahn SE, Nelson RG, et al. Disproportionately elevated proinsulin in Pima Indians with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990;70:1247-1253.
    • (1990) J Clin Endocrinol Metab , vol.70 , pp. 1247-1253
    • Saad, M.F.1    Kahn, S.E.2    Nelson, R.G.3
  • 27
    • 0027434701 scopus 로고
    • Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance
    • Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metab. 1993;76:44-48.
    • (1993) J Clin Endocrinol Metab , vol.76 , pp. 44-48
    • Reaven, G.M.1    Chen, Y.D.2    Hollenbeck, C.B.3    Sheu, W.H.4    Ostrega, D.5    Polonsky, K.S.6
  • 29
    • 9844258892 scopus 로고    scopus 로고
    • Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families
    • Humphriss DB, Stewart MW, Berrish TS, et al. Multiple metabolic abnormalities in normal glucose tolerant relatives of NIDDM families. Diabetologia. 1997;40:1185-1190.
    • (1997) Diabetologia , vol.40 , pp. 1185-1190
    • Humphriss, D.B.1    Stewart, M.W.2    Berrish, T.S.3
  • 30
    • 15944414254 scopus 로고    scopus 로고
    • Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: An 11-year follow-up of the Hoorn Study
    • Alssema M, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Proinsulin concentration is an independent predictor of all-cause and cardiovascular mortality: an 11-year follow-up of the Hoorn Study. Diabetes Care. 2005;28:860-865.
    • (2005) Diabetes Care , vol.28 , pp. 860-865
    • Alssema, M.1    Dekker, J.M.2    Nijpels, G.3    Stehouwer, C.D.4    Bouter, L.M.5    Heine, R.J.6
  • 31
    • 79955422864 scopus 로고    scopus 로고
    • Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance
    • Lee YA, Yoo JH, Kim JH, et al. Independent relationships of obesity and insulin resistance with serum proinsulin level in prepubertal children with normal glucose tolerance. Pediatr Diabetes. 2011;12: 235-241.
    • (2011) Pediatr Diabetes , vol.12 , pp. 235-241
    • Lee, Y.A.1    Yoo, J.H.2    Kim, J.H.3
  • 32
    • 84874537799 scopus 로고    scopus 로고
    • Association of proinsulin and hepatic steatosis in a random, population-based sample
    • Wengert S, Oeztuerk S, HaenleMM,et al. Association of proinsulin and hepatic steatosis in a random, population-based sample. Eur J Endocrinol. 2013;168:195-202.
    • (2013) Eur J Endocrinol , vol.168 , pp. 195-202
    • Wengert, S.1    Oeztuerk, S.2    Haenle, M.M.3
  • 33
    • 84876495093 scopus 로고    scopus 로고
    • Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study
    • Walraven I, van 't Riet E, Stehouwer CD, et al. Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study. Diabetologia. 2013;56:1148-1154.
    • (2013) Diabetologia , vol.56 , pp. 1148-1154
    • Walraven, I.1    Van 't Riet, E.2    Stehouwer, C.D.3
  • 34
    • 0036175966 scopus 로고    scopus 로고
    • Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes
    • Hanefeld M, Haffner SM, Menschikowski M, et al. Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with type 2 diabetes. Diabetes Res Clin Pract. 2002;55:221-227.
    • (2002) Diabetes Res Clin Pract , vol.55 , pp. 221-227
    • Hanefeld, M.1    Haffner, S.M.2    Menschikowski, M.3
  • 35
    • 77957659168 scopus 로고    scopus 로고
    • Limitations of the HOMA-score for assessment of-cell functionality in interventional trialsresults from the PIOglim study
    • Pfutzner A, Derwahl M, Jacob S, et al. Limitations of the HOMA-score for assessment of-cell functionality in interventional trialsresults from the PIOglim study. Diabetes Technol Ther. 2010;12: 599-604.
    • (2010) Diabetes Technol Ther , vol.12 , pp. 599-604
    • Pfutzner, A.1    Derwahl, M.2    Jacob, S.3
  • 36
    • 8944248809 scopus 로고    scopus 로고
    • Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with noninsulin-dependent (type 2) diabetes mellitus
    • Nagi DK, Ali VM, Yudkin JS. Effect of metformin on intact proinsulin and des 31,32 proinsulin concentrations in subjects with noninsulin-dependent (type 2) diabetes mellitus. Diabet Med. 1996;13: 753-757.
    • (1996) Diabet Med , vol.13 , pp. 753-757
    • Nagi, D.K.1    Ali, V.M.2    Yudkin, J.S.3
  • 37
    • 0033347050 scopus 로고    scopus 로고
    • Prolonged exposure of human-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine
    • Hostens K, Ling Z, Van Schravendijk C, Pipeleers D. Prolonged exposure of human-cells to high glucose increases their release of proinsulin during acute stimulation with glucose or arginine. J Clin Endocrinol Metab. 1999;84:1386-1390.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 1386-1390
    • Hostens, K.1    Ling, Z.2    Van Schravendijk, C.3    Pipeleers, D.4
  • 38
    • 0028559815 scopus 로고
    • Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome
    • Haffner SM, Mykkanen L, Valdez RA, et al. Disproportionately increased proinsulin levels are associated with the insulin resistance syndrome. J Clin Endocrinol Metab. 1994;79:1806-1810.
    • (1994) J Clin Endocrinol Metab , vol.79 , pp. 1806-1810
    • Haffner, S.M.1    Mykkanen, L.2    Valdez, R.A.3
  • 40
    • 79955773190 scopus 로고    scopus 로고
    • Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic-cells
    • Wang J, Chen Y, Yuan Q, Tang W, Zhang X, Osei K. Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic-cells. PLoS One. 2011;6:e19446.
    • (2011) PLoS One , vol.6 , pp. e19446
    • Wang, J.1    Chen, Y.2    Yuan, Q.3    Tang, W.4    Zhang, X.5    Osei, K.6
  • 41
    • 0027176926 scopus 로고
    • Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers
    • Lindgren FA, Hartling SG, Persson BE, et al. Proinsulin levels in newborn siblings of type 1 (insulin-dependent) diabetic children and their mothers. Diabetologia. 1993;36:560-563.
    • (1993) Diabetologia , vol.36 , pp. 560-563
    • Lindgren, F.A.1    Hartling, S.G.2    Persson, B.E.3
  • 42
    • 84878365678 scopus 로고    scopus 로고
    • The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: Implications in type 2 diabetes and islet transplantation
    • Park YJ,AoZ, Kieffer TJ, et al. The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation. Diabetologia. 2013;56:508-519.
    • (2013) Diabetologia , vol.56 , pp. 508-519
    • Park, Y.J.1    Ao, Z.2    Kieffer, T.J.3
  • 44
    • 84860324909 scopus 로고    scopus 로고
    • Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets
    • Alarcon C, Verchere CB, Rhodes CJ. Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. Endocrinology. 2012;153:2082-2087.
    • (2012) Endocrinology , vol.153 , pp. 2082-2087
    • Alarcon, C.1    Verchere, C.B.2    Rhodes, C.J.3
  • 45
    • 84861131970 scopus 로고    scopus 로고
    • Incretin-based therapies and cardiovascular risk
    • Mannucci E, Dicembrini I. Incretin-based therapies and cardiovascular risk. Curr Med Res Opin. 2012;28:715-721.
    • (2012) Curr Med Res Opin , vol.28 , pp. 715-721
    • Mannucci, E.1    Dicembrini, I.2
  • 46
    • 0028966170 scopus 로고
    • Expression and complex formation of soluble N-ethyl-maleimide-sensitive factor attachment protein (SNAP) receptors in clonal rat endocrine cells
    • Oho C, Seino S, Takahashi M. Expression and complex formation of soluble N-ethyl-maleimide-sensitive factor attachment protein (SNAP) receptors in clonal rat endocrine cells. Neurosci Lett. 1995; 186:208-210.
    • (1995) Neurosci Lett , vol.186 , pp. 208-210
    • Oho, C.1    Seino, S.2    Takahashi, M.3
  • 47
    • 0029983489 scopus 로고    scopus 로고
    • Protein kinase A-dependent phosphorylation ofGLUT2in pancreatic cells
    • Thorens B, Deriaz N, Bosco D, et al. Protein kinase A-dependent phosphorylation ofGLUT2in pancreatic cells. J Biol Chem. 1996; 271:8075-8081.
    • (1996) J Biol Chem , vol.271 , pp. 8075-8081
    • Thorens, B.1    Deriaz, N.2    Bosco, D.3
  • 48
    • 0242467078 scopus 로고    scopus 로고
    • PKAmediated phosphorylation of the human K(ATP) channel: Separate roles of Kir6. 2 and SUR1 subunit phosphorylation
    • Beguin P, Nagashima K, Nishimura M, Gonoi T, Seino S. PKAmediated phosphorylation of the human K(ATP) channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation.EMBOJ. 1999; 18:4722-4732.
    • (1999) EMBOJ , vol.18 , pp. 4722-4732
    • Beguin, P.1    Nagashima, K.2    Nishimura, M.3    Gonoi, T.4    Seino, S.5
  • 49
    • 0032545328 scopus 로고    scopus 로고
    • A family of cAMPbinding proteins that directly activate Rap1
    • Kawasaki H, Springett GM, Mochizuki N, et al. A family of cAMPbinding proteins that directly activate Rap1. Science. 1998;282: 2275-2279.
    • (1998) Science , vol.282 , pp. 2275-2279
    • Kawasaki, H.1    Springett, G.M.2    Mochizuki, N.3
  • 50
    • 33751241720 scopus 로고    scopus 로고
    • Epac proteins: Multi-purpose cAMP targets
    • Bos JL. Epac proteins: multi-purpose cAMP targets. Trends Biochem Sci. 2006;31:680-686.
    • (2006) Trends Biochem Sci , vol.31 , pp. 680-686
    • Bos, J.L.1
  • 51
    • 0033304977 scopus 로고    scopus 로고
    • Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic-cells independently of protein kinase A
    • Bode HP, Moormann B, Dabew R, Goke B. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic-cells independently of protein kinase A. Endocrinology. 1999;140:3919-3927.
    • (1999) Endocrinology , vol.140 , pp. 3919-3927
    • Bode, H.P.1    Moormann, B.2    Dabew, R.3    Goke, B.4
  • 52
    • 0027360242 scopus 로고
    • Pancreatic cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets
    • Ishihara H, Asano T, Tsukuda K, et al. Pancreatic cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets. Diabetologia. 1993;36:1139-1145.
    • (1993) Diabetologia , vol.36 , pp. 1139-1145
    • Ishihara, H.1    Asano, T.2    Tsukuda, K.3
  • 53
    • 0030033858 scopus 로고    scopus 로고
    • Glucoseregulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line
    • Skelly RH, Schuppin GT, Ishihara H, Oka Y, Rhodes CJ. Glucoseregulated translational control of proinsulin biosynthesis with that of the proinsulin endopeptidases PC2 and PC3 in the insulin-producing MIN6 cell line. Diabetes. 1996;45:37-43.
    • (1996) Diabetes , vol.45 , pp. 37-43
    • Skelly, R.H.1    Schuppin, G.T.2    Ishihara, H.3    Oka, Y.4    Rhodes, C.J.5
  • 54
    • 0028099196 scopus 로고
    • Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans
    • Martin SK, Carroll R, Benig M, Steiner DF. Regulation by glucose of the biosynthesis of PC2, PC3 and proinsulin in (ob/ob) mouse islets of Langerhans. FEBS Lett. 1994;356:279-282.
    • (1994) FEBS Lett , vol.356 , pp. 279-282
    • Martin, S.K.1    Carroll, R.2    Benig, M.3    Steiner, D.F.4
  • 55
    • 84868193842 scopus 로고    scopus 로고
    • Alocal glucagon-like peptide 1 (GLP-1) system in human pancreatic islets
    • Marchetti P, Lupi R, Bugliani M, et al.Alocal glucagon-like peptide 1 (GLP-1) system in human pancreatic islets. Diabetologia. 2012; 55:3262-3272.
    • (2012) Diabetologia , vol.55 , pp. 3262-3272
    • Marchetti, P.1    Lupi, R.2    Bugliani, M.3
  • 56
    • 80555157690 scopus 로고    scopus 로고
    • Processing of proglucagon to GLP-1 in pancreatic-cells: Is this a paracrine mechanism enabling GLP-1 to act on-cells?
    • Whalley NM, Pritchard LE, Smith DM, White A. Processing of proglucagon to GLP-1 in pancreatic-cells: is this a paracrine mechanism enabling GLP-1 to act on-cells? J Endocrinol. 2011;211:99-106.
    • (2011) J Endocrinol , vol.211 , pp. 99-106
    • Whalley, N.M.1    Pritchard, L.E.2    Smith, D.M.3    White, A.4
  • 57
    • 33748603481 scopus 로고    scopus 로고
    • Improving function and survival of pancreatic islets by endogenous production of glucagonlike peptide 1 (GLP-1)
    • Wideman RD, Yu IL, Webber TD, et al. Improving function and survival of pancreatic islets by endogenous production of glucagonlike peptide 1 (GLP-1). Proc Natl Acad Sci USA. 2006;103:13468-13473.
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 13468-13473
    • Wideman, R.D.1    Yu, I.L.2    Webber, T.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.